CytoLogix v. Ventana
This article was originally published in The Gray Sheet
Executive Summary
Damages of $25 mil.-$30 mil. are owed to CytoLogix after a Boston federal court patent infringement ruling permanently enjoins U.S. sales of Ventana Benchmark and Discovery slide staining systems, CytoLogix says May 20. The ruling follows a December jury finding (1"The Gray Sheet" Jan. 5, 2004, In Brief)...